Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune and molecular correlates in melanoma treated with immune checkpoint blockade.

Cancer - 1 Jun 2017

Byrne Elizabeth H, Fisher David E

Abstract excerpt

Immunotherapy for metastatic melanoma has a decades-long history, and the relatively recent use of checkpoint inhibitors has revolutionized treatment. Durable and sometimes complete remission of metastatic melanoma is now achievable in some patients who receive checkpoint-blocking therapy. However, it is unclear why some patients fare better than others. This review highlights several molecular indicators of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to B7-H1 Antigen
Share to Lymphocytes, Tumor-Infiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanocytes

Share to Microphthalmia-Associated Transcription Factor

Share to Nivolumab

Share to Programmed Cell Death 1 Receptor

Share to Vitiligo

Source

Open in PubMed Open full text

Identifiers

PMID: 28543699
DOI: 10.1002/cncr.30444
PMCID: PMC5445935

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune and molecular correlates in melanoma treated with immune checkpoint blockade.PMID 28543699Read ↗

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?Semantic proximity Read ↗

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity Read ↗

Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma.Semantic proximity Read ↗

Signaling and Immune Regulation in Melanoma Development and Responses to TherapySemantic proximity Read ↗

Signal pathways of melanoma and targeted therapySemantic proximity Read ↗

Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes.Semantic proximity Read ↗

Evolution of Molecular Targets in Melanoma Treatment.Semantic proximity Read ↗

Immunotherapy in Melanoma: A Dynamic Frontier in Cancer Treatment : Author List.Semantic proximity Read ↗

Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.Semantic proximity Read ↗

Interaction of molecular alterations with immune response in melanoma.Semantic proximity Read ↗

Understanding the biology of melanoma and therapeutic implications.Semantic proximity Read ↗

OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.